Mitochondrial Dysfunction in Huntington's Disease: Pathogenesis and Therapeutic Opportunities

Area of Science:

• Neuroscience
• Cell Biology
• Genetics

Background:

• Huntington's disease (HD) is a neurodegenerative disorder characterized by motor, psychiatric, and cognitive decline.
• HD pathogenesis is linked to expanded CAG repeats in the huntingtin gene, leading to mutant huntingtin protein (mHtt) aggregation.
• Mitochondria play crucial roles in neuronal function, including energy production, calcium homeostasis, and apoptosis.

Purpose of the Study:

• To review the critical role of mitochondria in HD pathogenesis.
• To elucidate how mHtt impacts mitochondrial function, trafficking, and homeostasis.
• To identify mitochondrial-based therapeutic targets for HD.

Main Methods:

• Review of recent findings on mitochondrial involvement in HD.
• Analysis of mHtt's effects on mitochondrial dynamics and cellular signaling.
• Examination of PGC-1α regulation and oxidative stress in HD.

Main Results:

• Mitochondrial dysfunction, including impaired biogenesis and altered dynamics, is evident in pre-symptomatic HD.
• mHtt disrupts mitochondrial homeostasis and increases susceptibility to oxidative stress.
• mHtt affects key regulators like PGC-1α, impacting neuronal bioenergetics.

Conclusions:

• Mitochondria are central to HD pathology, with mHtt significantly impairing their function.
• Targeting mitochondrial pathways offers promising therapeutic strategies for HD.
• Ongoing clinical trials are exploring mitochondrial-based interventions for HD treatment.